Michelle Ho

Michelle Ho, Ph.D. joined 5AM Ventures in 2018 as an Analyst and was promoted to Associate in 2020. Dr. Ho was previously at Fannin Innovation Studio where she was an Entrepreneurship Fellow leading R&D and business development for two early stage life science startups in Houston, TX. Prior to Fannin, Dr. Ho was a T32 Postdoctoral Fellow in the Department of Gynecologic Oncology at The University of Texas MD Anderson and the Department of Bioengineering at Rice University developing targeted gene therapy vectors for ovarian cancer treatment. Dr. Ho earned her Ph.D. in Bioengineering from Rice University developing next-generation virus-based gene therapy vectors through design-based capsid protein engineering. She received her B.S. in Bioengineering from the University of California – Berkeley. Dr. Ho is based in the San Francisco, CA office.